Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · SCHEDULE 13G

Moderna, Inc.

MRNANASDAQEQUITYCurrent

SEC Filing

Filed Aug 12, 2026Accepted Aug 12, 2026, 5:40 PM EDTCIK 1682852Accession 0001422849-26-000128
Share

Company context

Current securities

Recent company filings

  1. 8-K filingSep 1, 2026
  2. 4 filingAug 7, 2026
  3. 144 filingAug 5, 2026
  4. 10-Q filingJul 31, 2026
  5. Results of Operations and Financial ConditionJul 31, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗